Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VALUE Trial
NCT06395194Phase 3Completed
- Sponsor
- Oslo University Hospital
- Start
- Sep 1997
- Primary completion
- Sep 2003
- Modality
- Small Molecules
01
Overview
Phase 3, randomised, double-blind trial of valsartan in hypertension (HTN) (2 arms), sponsored by Oslo University Hospital. Primary endpoint: Time to first cardiac event up to 6 years. Started Sep 1997; status: completed.
02
Drugs
valsartan
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT06395194.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06395194.